Amiloxate is an organic molecule used as UV filter in sunscreen products. It is approved for use in the European Union (since 1997) and is undergoing regulatory evaluation in the United States.[1][2][3]
Names | |
---|---|
Preferred IUPAC name
3-Methylbutyl (2E)-3-(4-methoxyphenyl)prop-2-enoate | |
Other names
Isopentyl 4-methoxycinnamate; Isoamyl p-methoxycinnamate
| |
Identifiers | |
3D model (JSmol)
|
|
ChEMBL | |
ChemSpider | |
ECHA InfoCard | 100.068.798 |
PubChem CID
|
|
UNII | |
CompTox Dashboard (EPA)
|
|
| |
| |
Properties | |
C15H20O3 | |
Molar mass | 248.322 g·mol−1 |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
|
See also
editReferences
edit- ^ Brian Palmer (23 April 2014). "Burned by Bureaucracy: Why is the FDA stalling on newer and better sunscreens?". Slate.com.
- ^ Britt Erickson (May 12, 2014). "Sunscreen Delays". Chemical & Engineering News. 92 (19): 27. doi:10.1021/cen-09219-govpol2.
- ^ Garcia, Sandra E. (2023-08-12). "U.S. Sunscreen Is Stuck in the '90s. Is This a Job for Congress?". The New York Times. ISSN 0362-4331. Retrieved 2023-08-13.